New referral to the EBoA: post-filed experimental evidence and plausibility

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

New referral to the EBoA: post-filed experimental evidence and plausibility

Sponsored by

maiwald-logo-cropped.PNG
magnifip.png

Stefanie Parchmann of Maiwald considers the long-awaited referral to the Enlarged Board of Appeal regarding plausibility

At last – the long-awaited referral to the Enlarged Board of Appeal with respect to one of the most controversially discussed issues in European patent matters in recent times, i.e. plausibility, is here.

In the case, T 116/18, the Board of Appeal decided to refer three questions of law to the Enlarged Board of Appeal regarding plausibility and post-filed evidence (G 2/21).

The referral is made on the background of the long-standing practice of the Boards of Appeal that experimental evidence for the technical effect defined by applying the problem-solution approach may be submitted and taken into account to establish an inventive step, even though this evidence is not part of the application as filed. This practice was evolved in cases where the problem underlying the invention had to be reformulated as compared to the initial problem named in the application because of prior art found during examination or opposition proceedings.

In the wake of this practice, some boards requested that the said technical effect, even though it was formulated after the filing date of the application in question, and based on hitherto uncited prior art, nevertheless must at least be rendered plausible by the application as filed.

The Board in T 116/18 termed such technical effect rendered plausible by the application as filed as ‘ab-initio plausibility’. The Board of Appeal, however, also noted decisions in which this criterion for ab-initio plausibility was found to be incompatible with the problem solution approach because the applicant would be forced to cover a potentially extensive number of technical effects of an invention in the original application to ensure that these effects might later be taken into account when discussing inventive step.

The Board identified a further scenario it termed ‘ab-initio implausibility’. In this scenario, the question to be asked would be whether there were any reasons based on the common general knowledge to assume that the alleged technical effect was not obtained.

The Board also asked whether it was equitable to allow an opponent to rely on post-published evidence if the patentee was denied reliance on post-filed evidence to support plausibility?

The Board concluded that the following questions on plausibility and post-filed evidence required a referral to the Enlarged Board of Appeal (as summarised):

(1) Should post-filed data be disregarded if they are the sole evidence for a technical effect?

(2) Can post-filed data be taken into account if there is ab-initio plausibility?

(3) Can post-filed data be taken into account if there is ab-initio implausibility?

It remains to be seen whether the referral is admitted (already, there is a discussion breaking out whether the referral might be inadmissible because there is – contrary to the Board´s finding – neither a point of law of fundamental importance nor diverging case law to be decided upon) and, if so, which path the Enlarged Board of Appeal will cut through the thicket of opinions on plausibility.

 

Stefanie Parchmann

Partner, Maiwald

E: parchmann@maiwald.eu


more from across site and SHARED ros bottom lb

More from across our site

The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
IP experts gathered in San Francisco last week to discuss the changing global SEP landscape and new licensing models for AI infrastructure
SKW Schwarz partner Daniel Kendziur explains how new green claims rules are changing his workload and bringing him into direct contact with marketing, PR and government affairs teams
The government is targeting earlier resolution of SEP disputes while ruling out a standalone IPEC rate determination track and restrictions on injunctions
Ana Castedo, who brings a strong focus on patent litigation, will help build the firm’s IP litigation offering in Madrid
A former scientist, inventor and now a patent practice leader, Hanane Fathi Roswall shares her views on leadership, diversity, the rise of AI and the promise of the UPC
With rumours that a third IP judge could yet join the England and Wales High Court, we run through some potential names while practitioners outline the importance of a well-stocked bench
Gift this article